Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

208 Views

Poster Session: PK/PD Studies

619 - Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Sujata M. Bhavnani, PharmD; MS; FIDSA

Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, NY, United States

Co-Author(s)

JH

Jeffrey P. Hammel, MS

Director
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
HG

Harish Ganesan, MS

Institute for Clinical Pharmacodynamics
Plano, Texas, United States
MS

M. Courtney Safir, PharmD

Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
CR

Christopher M. Rubino, PharmD

Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
PA

Paul G. Ambrose, PharmD; MS; FIDSA

President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
KK

Kevin M. Krause, MBA

AN2
San Francisco, California, United States